MeVis Medical Solutions AG (ETR:M3V)
Germany flag Germany · Delayed Price · Currency is EUR
24.80
+0.20 (0.81%)
Feb 13, 2026, 5:35 PM CET

ETR:M3V Income Statement

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
16.0616.9717.3418.7616.21
Revenue Growth (YoY)
-5.36%-2.14%-7.57%15.71%-5.35%
Cost of Revenue
11.1810.5410.3410.179.29
Gross Profit
4.886.4378.596.92
Selling, General & Admin
0.550.550.560.560.47
Other Operating Expenses
1.871.751.481.481.31
Operating Expenses
2.562.432.142.131.91
Operating Income
2.3244.866.475.02
Interest Expense
-0-0.02-0--
Interest & Investment Income
0.090.150.11-0.16
Earnings From Equity Investments
---0.18-
Currency Exchange Gain (Loss)
-0.21-0.5-1.011.230.06
Other Non Operating Income (Expenses)
1.051.051.07--
EBT Excluding Unusual Items
3.264.695.037.885.24
Legal Settlements
-----0.61
Other Unusual Items
0.02----
Pretax Income
3.284.695.037.884.63
Income Tax Expense
0.110.130.110.090.09
Net Income
3.174.564.927.794.55
Net Income to Common
3.174.564.927.794.55
Net Income Growth
-30.58%-7.29%-36.84%71.35%-20.31%
Shares Outstanding (Basic)
22222
Shares Outstanding (Diluted)
22222
EPS (Basic)
1.742.512.704.282.50
EPS (Diluted)
1.742.512.704.282.50
EPS Growth
-30.58%-7.29%-36.84%71.35%-20.31%
Free Cash Flow
3.742.845.774.729.08
Free Cash Flow Per Share
2.051.563.172.604.99
Dividend Per Share
1.1301.1300.950--
Dividend Growth
-18.95%---
Gross Margin
30.38%37.91%40.38%45.80%42.70%
Operating Margin
14.44%23.58%28.05%34.46%30.94%
Profit Margin
19.71%26.87%28.37%41.52%28.04%
Free Cash Flow Margin
23.28%16.76%33.30%25.18%56.00%
EBITDA
2.474.134.966.565.14
EBITDA Margin
15.36%24.36%28.60%34.96%31.71%
D&A For EBITDA
0.150.130.10.090.13
EBIT
2.3244.866.475.02
EBIT Margin
14.44%23.58%28.05%34.46%30.94%
Effective Tax Rate
3.45%2.70%2.27%1.11%1.84%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.